Sovenyr
Get early access
Signal
2026-07-09
ClinicalTrials.gov
[PHASE1] A Phase Ib Study of Tislelizumab Plus SYS6010 in Immunotherapy-Pretreated Locally Advanced or Metastatic NSCLC
Part of
Cancer Immunotherapy And Combination Strategies
Open primary source
See the whole picture